XEOMIN 100SU Prášek pro injekční roztok Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

xeomin 100su prášek pro injekční roztok

merz pharmaceuticals gmbh, frankfurt am main array - 18988 botulotoxin (inkobotulin) typ a - prášek pro injekční roztok - 100su - botulotoxin

XEOMIN 200SU Prášek pro injekční roztok Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

xeomin 200su prášek pro injekční roztok

merz pharmaceuticals gmbh, frankfurt am main array - 18988 botulotoxin (inkobotulin) typ a - prášek pro injekční roztok - 200su - botulotoxin

XEOMIN 50SU Prášek pro injekční roztok Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

xeomin 50su prášek pro injekční roztok

merz pharmaceuticals gmbh, frankfurt am main array - 18988 botulotoxin (inkobotulin) typ a - prášek pro injekční roztok - 50su - botulotoxin

MELPHALAN ZENTIVA 50MG Prášek a rozpouštědlo pro injekční/infuzní roztok Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

melphalan zentiva 50mg prášek a rozpouštědlo pro injekční/infuzní roztok

zentiva, k.s., praha array - 21067 melfalan-hydrochlorid - prášek a rozpouštědlo pro injekční/infuzní roztok - 50mg - melfalan

Pombiliti Европейски съюз - чешки - EMA (European Medicines Agency)

pombiliti

amicus therapeutics europe limited - cipaglucosidase alfa - glykogen storage type ii - jiné zažívací trakt a produkty metabolismu, - pombiliti (cipaglucosidase alfa) is a long-term enzyme replacement therapy used in combination with the enzyme stabiliser miglustat for the treatment of adults with late-onset pompe disease (acid α-glucosidase [gaa] deficiency).

Virbagen Omega Европейски съюз - чешки - EMA (European Medicines Agency)

virbagen omega

virbac s.a. - recombinant omega interferon of feline origin - immunostimulants, - dogs; cats - dogsreduction of mortality and clinical signs of parvovirosis (enteric form) in dogs from one month of age. catstreatment of cats infected with feline leukaemia virus (felv) and / or feline immunodeficiency virus (fiv), in non-terminal clinical stages, from the age of nine weeks. in a field study conducted, it was observed that there was:a reduction of clinical signs during the symptomatic phase (four months);a reduction of mortality:in anaemic cats, mortality rate of about 60% at four, six, nine and 12 months was reduced by approximately 30% following treatment with interferon;in non-anaemic cats, mortality rate of 50% in cats infected by felv was reduced by 20% following treatment with interferon. in cats infected by fiv, mortality was low (5%) and was not influenced by the treatment.

DUTASTERID/TAMSULOSIN AUROVITAS 0,5MG/0,4MG Tvrdá tobolka Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

dutasterid/tamsulosin aurovitas 0,5mg/0,4mg tvrdá tobolka

aurovitas, spol. s r.o., praha ČeskÁ republika - 15483 dutasterid; 14672 tamsulosin-hydrochlorid - tvrdá tobolka - 0,5mg/0,4mg - tamsulosin a dutasterid

Agil® 100 EC Чехия - чешки - Adama

agil® 100 ec

adama - emulgovatelný koncentrát - propaquizafop - herbicidy

METOPIRONE 250MG Měkká tobolka Чехия - чешки - SUKL (Státní ústav pro kontrolu léčiv)

metopirone 250mg měkká tobolka

hra pharma rare diseases, chatillon array - 1749 metyrapon - měkká tobolka - 250mg - metyrapon